Parvaneh Hatami

574 total citations
58 papers, 352 citations indexed

About

Parvaneh Hatami is a scholar working on Dermatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Parvaneh Hatami has authored 58 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Dermatology, 22 papers in Pathology and Forensic Medicine and 10 papers in Genetics. Recurrent topics in Parvaneh Hatami's work include Autoimmune Bullous Skin Diseases (21 papers), Dermatological and COVID-19 studies (12 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Parvaneh Hatami is often cited by papers focused on Autoimmune Bullous Skin Diseases (21 papers), Dermatological and COVID-19 studies (12 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Parvaneh Hatami collaborates with scholars based in Iran, United States and United Kingdom. Parvaneh Hatami's co-authors include Zeinab Aryanian, Kamran Balighi, Azadeh Goodarzi, Maryam Ghiasi, Terrence M. Vance, Keramat Nourijelyani, Mohammad Amin Abbasi, Ata Abbasi, Maryam Daneshpazhooh and Robabeh Abedini and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Immunopharmacology and International Journal of Clinical Practice.

In The Last Decade

Parvaneh Hatami

48 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parvaneh Hatami Iran 11 168 125 87 54 52 58 352
Neetu Bhari India 10 105 0.6× 97 0.8× 33 0.4× 45 0.8× 25 0.5× 83 334
Amer N. Kalaaji United States 12 98 0.6× 143 1.1× 45 0.5× 66 1.2× 42 0.8× 32 336
J. Romaní Spain 15 309 1.8× 64 0.5× 116 1.3× 18 0.3× 44 0.8× 52 615
Zafer Türkoğlu Türkiye 10 102 0.6× 115 0.9× 29 0.3× 47 0.9× 12 0.2× 54 295
Gitesh U. Sawatkar India 10 53 0.3× 139 1.1× 28 0.3× 97 1.8× 45 0.9× 27 262
Javier Alonso‐Llamazares United States 10 119 0.7× 148 1.2× 86 1.0× 47 0.9× 26 0.5× 30 344
Karima Senouci Morocco 9 100 0.6× 99 0.8× 26 0.3× 30 0.6× 20 0.4× 131 295
O Mourellou Greece 11 106 0.6× 167 1.3× 32 0.4× 70 1.3× 12 0.2× 18 344
Maryam Akhyani Iran 12 259 1.5× 309 2.5× 126 1.4× 155 2.9× 14 0.3× 27 688
Sascha Ständer Germany 10 100 0.6× 112 0.9× 44 0.5× 83 1.5× 21 0.4× 30 260

Countries citing papers authored by Parvaneh Hatami

Since Specialization
Citations

This map shows the geographic impact of Parvaneh Hatami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parvaneh Hatami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parvaneh Hatami more than expected).

Fields of papers citing papers by Parvaneh Hatami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parvaneh Hatami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parvaneh Hatami. The network helps show where Parvaneh Hatami may publish in the future.

Co-authorship network of co-authors of Parvaneh Hatami

This figure shows the co-authorship network connecting the top 25 collaborators of Parvaneh Hatami. A scholar is included among the top collaborators of Parvaneh Hatami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parvaneh Hatami. Parvaneh Hatami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aryanian, Zeinab, et al.. (2024). A Comparative Study of Demographic and Clinical Criteria Between Male and Female Patients With Pemphigus Referred to a Referral Hospital in Iran. Dermatology Research and Practice. 2024(1). 9572303–9572303.
3.
Aryanian, Zeinab, et al.. (2024). Clinicopathological Spectrum of Facial Granulomatous Dermatoses: Evidence from a 5-Year Study in Iran. Dermatology Research and Practice. 2024. 1–6.
4.
Aryanian, Zeinab, et al.. (2024). Trichoscopic findings in children and adults with alopecia areata: A comparative study. Journal of Cosmetic Dermatology. 23(8). 2736–2742. 2 indexed citations
5.
Behrangi, Elham, Alireza Jafarzadeh, Masoumeh Roohaninasab, et al.. (2024). Assessing the Concordance of Clinical and Pathological Diagnoses in Basal Cell Carcinoma Among the Iranian Population: A Cross‐Sectional Analysis of 229 Cases. Cancer Reports. 7(10). e70040–e70040. 1 indexed citations
6.
Balighi, Kamran, et al.. (2024). Analysis of Hospitalization Cases for Filler Injection Complications: A Five‐Year Retrospective Study Among Iranian People. Journal of Cosmetic Dermatology. 24(2). e16733–e16733.
7.
Balighi, Kamran, et al.. (2023). Kaposi's sarcoma in a patient with pemphigus vulgaris mimicking exacerbation of pemphigus. Cancer Reports. 6(5). e1815–e1815. 2 indexed citations
8.
Aryanian, Zeinab, et al.. (2023). The impact of the COVID‐19 pandemic on the diagnosis and treatment of skin cancers, a mini review. Cancer Reports. 6(9). e1854–e1854. 3 indexed citations
9.
Aryanian, Zeinab, Kamran Balighi, Seyed Naser Emadi, & Parvaneh Hatami. (2023). Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?. Journal of Cosmetic Dermatology. 23(2). 406–408.
10.
Balighi, Kamran, et al.. (2023). A case report of esophageal cancer in a patient with pemphigus vulgaris: A coincidence or something beyond that?. Cancer Reports. 6(12). e1896–e1896. 1 indexed citations
11.
Hatami, Parvaneh, et al.. (2023). Isotretinoin and timing of procedural interventions: Clinical implications and practical points. Journal of Cosmetic Dermatology. 22(8). 2146–2149. 2 indexed citations
12.
Ehsani, Amir Houshang, et al.. (2023). Striae gravidarum treatment: evaluating non-ablating fractional laser (NAFL) efficacy and safety. Journal of Cosmetic and Laser Therapy. 25(1-4). 20–24.
13.
Afshar, Zeinab Mohseni, et al.. (2022). A Comparison of SARS-CoV-2 Infection-related and COVID-19 Vaccine-related Herpes Zoster; A Narrative Review. Journal of Pharmaceutical Negative Results. 13(SO3). 1 indexed citations
14.
Hatami, Parvaneh, et al.. (2022). Unmasking sarcoidosis following SARS‐CoV ‐2 vaccination: A case report. SHILAP Revista de lepidopterología. 10(12). e6660–e6660. 6 indexed citations
15.
Hatami, Parvaneh, et al.. (2022). Serious health threat of mucormycosis during the ongoing COVID‐19 pandemic: what dermatologists need to know in this regard. International Journal of Dermatology. 61(8). 979–981. 7 indexed citations
16.
Aryanian, Zeinab, Kamran Balighi, Arghavan Azizpour, Kambiz Kamyab Hesari, & Parvaneh Hatami. (2022). Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination. Case Reports in Dermatological Medicine. 2022. 1–5. 8 indexed citations
17.
Ehsani, Amir Hooshang, et al.. (2021). Effect of Different Pulse Durations on the Efficacy of Long-Pulsed Alexandrite-Assisted Hair Removal; A Split-Face Comparison Study. Journal of lasers in medical sciences. 12(1). e21–e21. 5 indexed citations
18.
19.
Hatami, Parvaneh, et al.. (2021). A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata. International Immunopharmacology. 101(Pt B). 108186–108186. 12 indexed citations
20.
Hatami, Parvaneh, et al.. (2012). Randomized trial of tacrolimus 0.1% ointment versus triamcinolone acetonide 0.1% paste in the treatment of oral pemphigus vulgaris. 15(260). 42–46. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neetu Bhari Breakdown of academic impact, for papers by Amer N. Kalaaji Breakdown of academic impact, for papers by J. Romaní Breakdown of academic impact, for papers by Zafer Türkoğlu Breakdown of academic impact, for papers by Gitesh U. Sawatkar Breakdown of academic impact, for papers by Javier Alonso‐Llamazares Breakdown of academic impact, for papers by Karima Senouci Breakdown of academic impact, for papers by O Mourellou Breakdown of academic impact, for papers by Maryam Akhyani Breakdown of academic impact, for papers by Sascha Ständer
Rankless by CCL
2026